Enlivex Ltd. (ENLV) vs Purple Biotech Ltd. Sponsored ADR (PPBT)

Enlivex Ltd. and Purple Biotech Ltd. Sponsored ADR are both Biotechnology companies. Enlivex Ltd. and Purple Biotech Ltd. Sponsored ADR are of similar size ($2.0M and $2.0M). Purple Biotech Ltd. Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Enlivex Ltd. trades at 0.0×. Across the 11 metrics below, Enlivex Ltd. leads on 7 and Purple Biotech Ltd. Sponsored ADR on 4.

Valuation

Metric ENLV PPBT Biotechnology median
P/E 0.00 n/m 10.60
P/S n/m n/m 9.40
P/B 0.00 0.11 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 240.80 0.15 0.66
EV/Sales n/m n/m 9.02
Earnings yield 657,517.54% (3,843.12%) (32.88%)
Free cash flow yield (798.45%) (573.06%) (23.13%)

Profitability

Metric ENLV PPBT Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 159.77% (110.67%) (51.96%)
Return on assets 127.16% (100.91%) (46.06%)
Return on invested capital (5.85%) (290.25%) 0.00%

Growth

Metric ENLV PPBT Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 3,580.76% (10.14%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENLV PPBT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 119.39 3.70 4.97
Net debt to EBITDA 118.29 0.35 1.01

Dividend

Metric ENLV PPBT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ENLV PPBT Biotechnology median
Market cap 1.95m 2.03m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack